{"transactions":[{"id":946627,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2026-01-06T21:15:06.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in equal monthly installments over a one-year period measured from one month following January 2, 2026, subject to the Reporting Person's continuous service as of each applicable vesting date."}],"balance_after":90000,"derivative":{"exercise_price":2.05,"expiration_date":"2036-01-02","underlying":"Ordinary Shares","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001717972-26-000003","document":"form4-01062026_040101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000171797226000003/form4-01062026_040101.xml","form_type":"4"}},{"id":1310494,"issuer":{"id":5028,"kind":"organization","name":"Silence Therapeutics plc"},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2025-01-06T21:15:13.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in equal monthly installments over a three-year period measured from one month following January 2, 2025, subject to the Reporting Person's continuous service as of each applicable vesting date."}],"balance_after":48000,"derivative":{"exercise_price":2.4,"expiration_date":"2035-01-02","underlying":"Ordinary Shares","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001415889-25-000746","document":"form4-01062025_040109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479615/000141588925000746/form4-01062025_040109.xml","form_type":"4"}},{"id":1383931,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-18T09:10:30.000Z","date":"2024-10-17","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":0.9,"value":1800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market purchase by the reporting person of 2,000 shares of common stock, par value $0.0001 per share."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0000950170-24-115450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717972/000095017024115450/ownership.xml","form_type":"4"}},{"id":1468572,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2024-06-26T21:29:00.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":1.37,"expiration_date":"2034-03-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-078114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717972/000095017024078114/ownership.xml","form_type":"4"}},{"id":2053497,"issuer":{"id":7345,"kind":"organization","name":"Scilex Holding Co"},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonstatutory Stock Option (right to buy)","published_at":"2023-01-17T17:28:24.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Party's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":8.08,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000899243-23-001872","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717972/000089924323001872/doc4.xml","form_type":"4"}},{"id":2587350,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-08-30T20:13:44.000Z","date":"2021-08-30","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the original number of shares subject to this option shall vest and become exercisable on September 30, 2021, and 1/48th of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":8.86,"expiration_date":"2031-08-30","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-21-053983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000120919121053983/doc4.xml","form_type":"4"}},{"id":3111132,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-06-15T18:10:21.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the original number of shares subject to this option shall vest and become exercisable on July 15, 2020, and 1/12th of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date."}],"balance_after":100000,"derivative":{"exercise_price":4.89,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000850261-20-000045","document":"wf-form4_159225900329337.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026120000045/wf-form4_159225900329337.xml","form_type":"4"}},{"id":3551258,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-04-23T21:02:52.000Z","date":"2019-04-19","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the original number of shares subject to this option shall vest and become exercisable on May 14, 2019 and following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date."}],"balance_after":70000,"derivative":{"exercise_price":3.78,"expiration_date":"2029-04-19","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000850261-19-000015","document":"wf-form4_155606775780923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026119000015/wf-form4_155606775780923.xml","form_type":"4"}},{"id":3752510,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-11-27T19:47:51.000Z","date":"2018-11-26","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date."}],"balance_after":35000,"derivative":{"exercise_price":3.57,"expiration_date":"2028-11-26","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000850261-18-000043","document":"wf-form4_154336605538232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000085026118000043/wf-form4_154336605538232.xml","form_type":"4"}},{"id":4161170,"issuer":{"id":109201,"kind":"organization","name":"Sorrento Therapeutics, Inc."},"owners":[{"id":69996,"kind":"person","name":"Lemus David","position":1,"cik":"0001717972","reported_name":"Lemus David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-11-16T19:22:10.000Z","date":"2017-11-14","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12 of the original number of shares subject to this option is immediately vested and exercisable. 1/12 of the original number of shares subject to this option shall vest and become exercisable on November 26, 2017 and 1/12 of the original number of shares subject to the option shall vest following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date."}],"balance_after":35000,"derivative":{"exercise_price":2.3,"expiration_date":"2027-11-14","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-17-059793","document":"tv479803_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/850261/000114420417059793/tv479803_4.xml","form_type":"4"}}]}